Investors in life science


Leadership in life science investing

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Our mission is to enable and to make a positive and meaningful impact on health, science and society by generating attractive, long-term investment returns on our holdings and investments.

Holdings and investments

We are the holding company of the Novo Group and manage the investment assets of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities.

Our people embrace a culture of high performance with high responsibility

Novo Holdings employs over 70 investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.

Annual review

Selected key figures

  • 37 bn

    Total assets of Novo Holdings at the end of 2016.

  • 21 %

    Return on Life Science investments (IRR) last 5 years.

  • 11 %

    Return on Financial investments (IRR) last 5 years.

Our locations

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
+45 3527 6500

CVR# 24257630

Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02142

Novo Ventures (US) Inc.*
1700 Owens Street, Suite 540
San Francisco, CA 94158

+1 (415) 552-6686

*Novo Ventures (US) Inc. is a separate legal entity that provides certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more